- Corporate Officers - D
- Dhingra Ankur
Insider Trading History of Dhingra Ankur
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dhingra Ankur since 2021.
This trader's CIK number is 1849682.
At the time of last reporting, Dhingra Ankur was the SVP, Chief Financial Officer of Illumina, Inc.. (stock ticker symbol ILMN).
Also see all insider trading activities at Illumina, Inc..
Note that in the past
Dhingra Ankur also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Illumina, Inc. (ILMN) by Dhingra Ankur
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2025 | ILMN | 6,100 | $495,380 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Caredx, Inc. (CDNA) by Dhingra Ankur
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | CDNA | 5,000 | $211,695 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Summit Therapeutics Inc. (SMMT) by Dhingra Ankur
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | SMMT | 100,000 | $375,000 | 0 | $0 | 0 | $0 |
| 2023 | SMMT | 216,762 | $250,244 | 0 | $0 | 0 | $0 |
| 2022 | SMMT | 36,215 | $35,128 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Dhingra Ankur:
1. Illumina, Inc. (ILMN)
2. Caredx, Inc. (CDNA)
3. Summit Therapeutics Inc. (SMMT)
Table 1. Insider trading of Illumina, Inc. (ILMN) by Dhingra Ankur
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2025-05-12 | ILMN | Buy | 6,100 | 81.21 | 495,380 |
Table 2. Insider trading of Caredx, Inc. (CDNA) by Dhingra Ankur
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-11-24 | CDNA | Buy | 5,000 | 42.34 | 211,695 |
Table 3. Insider trading of Summit Therapeutics Inc. (SMMT) by Dhingra Ankur
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-03-26 | SMMT | Buy | 100,000 | 3.75 | 375,000 |
| 2023-12-13 | SMMT | Buy | 20,400 | 2.16 | 44,064 |
| 2023-03-07 | SMMT | Buy | 196,362 | 1.05 | 206,180 |
| 2022-08-16 | SMMT | Buy | 36,215 | .97 | 35,128 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Dhingra Ankur
(SVP, Chief Financial Officer of Illumina, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.